Bristol-Myers Squibb Company (BMY) EBITDA History
| Quarter End | EBITDA
$ 000,000's
|
|---|---|
| 2023-Dec-31 | 4,148 |
| 2023-Sep-30 | 4,215 |
| 2023-Jun-30 | 4,626 |
| 2023-Mar-31 | 5,096 |
| 2022-Dec-31 | 4,493 |
| 2022-Sep-30 | 4,795 |
| 2022-Jun-30 | 4,533 |
| 2022-Mar-31 | 4,266 |
| 2021-Dec-31 | 4,457 |
| 2021-Sep-30 | 5,206 |
| 2021-Jun-30 | 4,589 |
| 2021-Mar-31 | 5,543 |
| 2020-Dec-31 | -7,406 |
| 2020-Sep-30 | 5,252 |
| 2020-Jun-30 | 4,537 |
Full historical financial data for Bristol-Myers Squibb Company for 1987 - 2023 is included in the
US Historical Financials dataset.